# Selective Activation of the Adrenomedullin Receptors in Migraine

> **NCT07451769** · NA · NOT_YET_RECRUITING · sponsor: **Danish Headache Center** · enrollment: 26 (estimated)

## Conditions studied

- Migraine
- Brain Diseases
- Central Nervous System Diseases
- Adrenomedullin
- Pain
- Peptides
- Neuropeptides
- Signs and Symptoms

## Interventions

- **DRUG:** Adrenomedullin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07451769
- **Lead sponsor:** Danish Headache Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-10
- **Primary completion:** 2027-03-10
- **Final completion:** 2032-12-20
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2026-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07451769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07451769, "Selective Activation of the Adrenomedullin Receptors in Migraine". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07451769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*